- Work address
-
Ottergemsesteenweg 460
9000 Gent - FilipX.DeVos@UGent.be
- ORCID iD
-
0000-0003-4702-6702
Show
Sort by
-
- Journal Article
- A1
- open access
Preclinical comparative study of [18F]AlF-PSMA-11 and [18F]PSMA-1007 in varying PSMA expressing tumors
-
- Journal Article
- A1
- open access
Accelerated HF‐rTMS modifies SERT availability in the subgenual anterior cingulate cortex : a canine [11C]DASB study on the serotonergic system
-
- Journal Article
- A1
- open access
Recent advancements in 18F-labeled PSMA targeting PET radiopharmaceuticals
-
- Journal Article
- A1
- open access
Impact of the molar activity and PSMA expression level on [18F]AlF-PSMA-11 uptake in prostate cancer
-
- Journal Article
- A1
- open access
Assessment of the effect of therapy in a rat model of glioblastoma using [18F]FDG and [18F]FCho PET compared to contrast-enhanced MRI
-
- Journal Article
- A1
- open access
Intra-individual dynamic comparison of 18F-PSMA-11 and 68Ga-PSMA-11 in LNCaP xenograft bearing mice
-
- Journal Article
- A1
- open access
Development of a rat model for glioma-related epilepsy
-
- Journal Article
- A1
- open access
Radiosynthesis, in vitro and preliminary biological evaluation of [F-18]2-amino-4-((2-((3-fluorobenzyl)oxy)benzyl)(2-((3-(fluoromethyl)benzyl)oxy)benzyl)amino) butanoic acid, a novel alanine serine cysteine transporter 2 inhibitor-based positron emission tomography tracer
-
Radiosynthesis, in vitro and preliminary in vivo evaluation of the novel glutamine derived PET tracers [18F]fluorophenylglutamine and [18F]fluorobiphenylglutamine
-
- Journal Article
- A1
- open access
Optimization of PET protocol and interrater reliability of 18F-PSMA-11 imaging of prostate cancer